Intra-patient dose escalation (IPDE) of ripretinib after disease progression in patients with advanced gastrointestinal stromal tumor (GIST): Analyses from the phase 3 INVICTUS study Meeting Abstract
| Authors: | Zalcberg, J. R.; Heinrich, M. C.; George, S.; Bauer, S.; Schoffski, P.; Serrano, C.; Jones, R. L.; Gelderblom, H.; Attia, S.; D'Amato, G. Z.; Chi, P.; Reichardt, P.; Somaiah, N.; Meade, J. N.; Reichert, V. L.; Shi, K.; Sherman, M. L.; Ruiz-Soto, R.; von Mehren, M.; Blay, J. Y. |
| Abstract Title: | Intra-patient dose escalation (IPDE) of ripretinib after disease progression in patients with advanced gastrointestinal stromal tumor (GIST): Analyses from the phase 3 INVICTUS study |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120606073 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.11536 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11536 -- Source: Wos |
